-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on PACS Group, Raises Price Target to $42

Benzinga·03/04/2026 14:03:04
Listen to the news
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $40 to $42.